the effect on hepatocarcinogenesis of sequential administration of the antihistaminic drug methapyrilene ( mp ) or the typical liver tumor promoter , phenobarbital ( pb ) , each given after the genotoxic liver carcinogen , n-2-fluorenylacetamide ( faa ) was studied .
C1512409
hepatocarcinogenesis
C0023884
liver